SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021947
Filing Date
2023-05-15
Accepted
2023-05-15 07:01:15
Documents
51
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-20230331.htm   iXBRL 10-Q 1109771
2 EX-31.1 nerv-ex31_1.htm EX-31.1 19174
3 EX-31.2 nerv-ex31_2.htm EX-31.2 18541
4 EX-32.1 nerv-ex32_1.htm EX-32.1 16551
  Complete submission text file 0000950170-23-021947.txt   4289240

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nerv-20230331_pre.xml EX-101.PRE 222343
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nerv-20230331.xsd EX-101.SCH 36019
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nerv-20230331_lab.xml EX-101.LAB 298312
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nerv-20230331_def.xml EX-101.DEF 124683
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nerv-20230331_cal.xml EX-101.CAL 23703
45 EXTRACTED XBRL INSTANCE DOCUMENT nerv-20230331_htm.xml XML 577186
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 23918329
SIC: 2834 Pharmaceutical Preparations